0001209191-22-044894.txt : 20220808
0001209191-22-044894.hdr.sgml : 20220808
20220808193312
ACCESSION NUMBER: 0001209191-22-044894
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220804
FILED AS OF DATE: 20220808
DATE AS OF CHANGE: 20220808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KANAYA SUSAN M
CENTRAL INDEX KEY: 0001226064
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 221145995
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 835 INDUSTRIAL ROAD
STREET 2: SUITE 600
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 835 INDUSTRIAL ROAD
STREET 2: SUITE 600
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-04
0
0001340652
ChemoCentryx, Inc.
CCXI
0001226064
KANAYA SUSAN M
C/O CHEMOCENTRYX, INC.
835 INDUSTRIAL ROAD, SUITE 600
SAN CARLOS
CA
94070
1
1
0
0
EVP, CFO and Sec.
Common Stock
2022-08-04
4
M
0
14583
6.23
A
105900
D
Common Stock
2022-08-04
4
M
0
31715
6.62
A
137615
D
Common Stock
2022-08-04
4
S
0
46298
50.1688
D
91317
D
Common Stock
132717
I
Kanaya Family Trust U/A Dtd 10/17/2012
Stock Option (right to buy)
6.23
2022-08-04
4
M
0
14583
D
2026-10-24
Common Stock
14583
30209
D
Stock Option (right to buy)
6.62
2022-08-04
4
M
0
31715
D
2027-02-28
Common Stock
31715
76702
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $50.06 to $50.35 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
As of August 4, 2022, and prior to this transaction, the exercised options were fully vested.
Not applicable.
/s/ Susan M. Kanaya
2022-08-08